Oct 13, 2025 17:00
BMY - Bristol-Myers Squibb Co.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
43.91 -0.3 (-0.68%) | --- | --- | --- | -0.21 (-0.48%) | -0.16 (-0.37%) | -0.01 (-0.02%) | -0.01 (-0.02%) |
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- 0.64
- Diluted EPS:
- 0.64
- Basic P/E:
- 68.1406
- Diluted P/E:
- 68.1406
- RSI(14) 1m:
- 0.0
- VWAP:
- 43.61
- RVol:
- 0.5296
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Oct 13, 2025 13:00
Oct 10, 2025 14:32
Oct 08, 2025 17:00
Oct 08, 2025 15:00
Sep 30, 2025 15:00
Sep 29, 2025 13:00
Sep 23, 2025 17:07
Sep 22, 2025 17:00
Sep 22, 2025 13:00